Evidence map›Paper›PMID 31777939›Full record

ArticleNucleic acids research2020

Discovery of a new predominant cytosine DNA modification that is linked to gene expression in malaria parasites.

Elie Hammam, Guruprasad Ananda, Ameya Sinha, Christine Scheidig-Benatar, Mylene Bohec, Peter R Preiser, Peter C Dedon, Artur Scherf, Shruthi S Vembar

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Epigenetics and chromatin structure regulatebioRxiv : the preprint server for biology · 2026
    Article
  3. Frontiers in cellular and infection microbiology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. A Drug Repurposing Approach Reveals Targetable Epigenetic Pathways inbioRxiv : the preprint server for biology · 2024
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. 5-methylcytosine modification byProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 3 countries.

Elie HammamInstitut Pasteur, 75015 Paris, France.
Guruprasad AnandaThe Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA.
Ameya SinhaAntimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology, Singapore 138602, Singapore.
Christine Scheidig-BenatarInstitut Pasteur, 75015 Paris, France.
Mylene BohecInstitut Curie Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, 75005 Paris, France.
Peter R PreiserAntimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology, Singapore 138602, Singapore.
Peter C DedonAntimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology, Singapore 138602, Singapore.
Artur ScherfInstitut Pasteur, 75015 Paris, France.
Shruthi S VembarInstitut Pasteur, 75015 Paris, France.
Centre National de la Recherche Scientifique · FRNanyang Technological University · SGInserm · FRInstitut Curie · FRInstitut Pasteur · FRJackson Laboratory · USSingapore-MIT Alliance for Research and Technology · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA cytosine modifications are key epigenetic regulators of cellular processes in mammalian cells, with their misregulation leading to varied disease states. In the human malaria parasite Plasmodium falciparum, a unicellular eukaryotic pathogen, little is known about the predominant cytosine modifications, cytosine methylation (5mC) and hydroxymethylation (5hmC). Here, we report the first identification of a hydroxymethylcytosine-like (5hmC-like) modification in P. falciparum asexual blood stages using a suite of biochemical methods. In contrast to mammalian cells, we report 5hmC-like levels in the P. falciparum genome of 0.2-0.4%, which are significantly higher than the methylated cytosine (mC) levels of 0.01-0.05%. Immunoprecipitation of hydroxymethylated DNA followed by next generation sequencing (hmeDIP-seq) revealed that 5hmC-like modifications are enriched in gene bodies with minimal dynamic changes during asexual development. Moreover, levels of the 5hmC-like base in gene bodies positively correlated to transcript levels, with more than 2000 genes stably marked with this modification throughout asexual development. Our work highlights the existence of a new predominant cytosine DNA modification pathway in P. falciparum and opens up exciting avenues for gene regulation research and the development of antimalarials.

Indexed as

Epigenesis, GeneticGenome, Protozoan5-MethylcytosineCytosineDNA MethylationDNA, ProtozoanErythrocytesHigh-Throughput Nucleotide SequencingHumansHydroxylationPlasmodium falciparumRNA, Messenger5-hydroxymethylcytosine5-MethylcytosineCytosineDNA, ProtozoanRNA, Messenger

Identifiers

PMID31777939
PMCPMC6943133
OpenAlexW2991313286

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.